Literature DB >> 9312058

Induced N- and C-terminal cleavage of p53: a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ssDNA induces C-terminal cleavage of p53.

A L Okorokov1, F Ponchel, J Milner.   

Abstract

p53 is able to recognize and bind sites of DNA damage and, in some way, damage to cellular DNA activates a p53 response leading to G1 arrest or apoptosis. We have previously shown that 'damaged DNA' induces N-terminal cleavage of p53 to generate p40(DeltaN) and p35 (core) protein products. We now show that the p35 product has protease activity and is able to cleave between residues 23 and 24 of full-length p53 to generate a novel product, p50(DeltaN23). This activity was inhibited by bestatin, an aminopeptidase inhibitor. Residues 23 and 24 lie within the mdm-2 binding domain of p53 and the possibility that p50(DeltaN23) may be resistant to feedback regulation by mdm-2 is discussed. Unexpectedly, interaction with ssDNA induced two further cleavage products of p53, generated by C-terminal cleavage and designated p50(DeltaC) and p40(DeltaC). In vivo generation of a C-terminal cleavage product of endogenous p53 similar in size to p50(DeltaC) correlated with up-regulation of p21 expression in ML-1 cells exposed to either adriamycin or cisplatin. The possible significance of the various p53 cleavage products in relation to the cellular response to DNA damage is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9312058      PMCID: PMC1170231          DOI: 10.1093/emboj/16.19.6008

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  45 in total

1.  Regulation of the specific DNA binding function of p53.

Authors:  T R Hupp; D W Meek; C A Midgley; D P Lane
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

2.  Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.

Authors:  J Milner; E A Medcalf; A C Cook
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

3.  Interaction with damaged DNA induces selective proteolytic cleavage of p53 to yield 40 kDa and 35 kDa fragments competent for sequence-specific DNA binding.

Authors:  M Molinari; A L Okorokov; J Milner
Journal:  Oncogene       Date:  1996-11-21       Impact factor: 9.867

4.  The murine C'-terminally alternatively spliced form of p53 induces attenuated apoptosis in myeloid cells.

Authors:  N Almog; R Li; A Peled; D Schwartz; R Wolkowicz; N Goldfinger; H Pei; V Rotter
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

5.  Carcinoma of the esophagus--current imaging options.

Authors:  C R Taylor
Journal:  Am J Gastroenterol       Date:  1986-11       Impact factor: 10.864

6.  Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents.

Authors:  R B Tishler; S K Calderwood; C N Coleman; B D Price
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

7.  The multiple roles for ATP in the Escherichia coli UvrABC endonuclease-catalyzed incision reaction.

Authors:  S Thiagalingam; L Grossman
Journal:  J Biol Chem       Date:  1993-08-25       Impact factor: 5.157

8.  Translational regulation of human p53 gene expression.

Authors:  L Fu; M D Minden; S Benchimol
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

9.  Evidence for allosteric variants of wild-type p53, a tumour suppressor protein.

Authors:  A Cook; J Milner
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

10.  p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.

Authors:  X Chen; L J Ko; L Jayaraman; C Prives
Journal:  Genes Dev       Date:  1996-10-01       Impact factor: 11.361

View more
  13 in total

1.  An ATP/ADP-dependent molecular switch regulates the stability of p53-DNA complexes.

Authors:  A L Okorokov; J Milner
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  In vitro evolution of thermostable p53 variants.

Authors:  I Matsumura; A D Ellington
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

3.  Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding.

Authors:  F Janus; N Albrechtsen; U Knippschild; L Wiesmüller; F Grosse; W Deppert
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

4.  The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity.

Authors:  Andrei L Okorokov; Michael B Sherman; Celia Plisson; Vera Grinkevich; Kristmundur Sigmundsson; Galina Selivanova; Jo Milner; Elena V Orlova
Journal:  EMBO J       Date:  2006-10-19       Impact factor: 11.598

5.  The C terminus of p53 family proteins is a cell fate determinant.

Authors:  Kelly Lynn Harms; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

6.  Nonsense mutation-dependent reinitiation of translation in mammalian cells.

Authors:  Sarit Cohen; Lior Kramarski; Shahar Levi; Noa Deshe; Oshrit Ben David; Eyal Arbely
Journal:  Nucleic Acids Res       Date:  2019-07-09       Impact factor: 16.971

7.  Activation of caspases and p53 by bovine herpesvirus 1 infection results in programmed cell death and efficient virus release.

Authors:  L R Devireddy; C J Jones
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

8.  Doxorubicin and octreotide induce a 40 kDa breakdown product of p53 in human hepatoma and tumoral colon cell lines.

Authors:  Zahia Sadji-Ouatas; Malika Lasfer; Sophie Julien; Gérard Feldmann; Florence Reyl-Desmars
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

9.  Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation.

Authors:  M Kapoor; G Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

10.  Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression.

Authors:  S T Suhr; M C Senut; J P Whitelegge; K F Faull; D B Cuizon; F H Gage
Journal:  J Cell Biol       Date:  2001-04-16       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.